NanoPass developed the smallest FDA-approved microneedle
Published in TechTime. The needle, less than 1 millimeter, is manufactured using MEMS technology. It is intended for vaccines and painless medicines injection. The company announced production agreement with Korean M2N.
Nanopass' intradermal device is ready for commercialization with Vaccines ( Kan 11 TV channel)
Israel's national broadcast service (Kan 11) interviewed Nanopass Technologies on its intradermal platform for its daily financial TV show.